Moreover, we detected a significantly higher percentage of BDCA-1+CD19−PD-L2+ DCs in the tumor tissue in comparison to PB of the OC patients (p < 0.0001; median 24.01% vs. 2.94%; Figure 2B). Here, CD1C is linked to neoplasm.